MMarkets Read More Samsung Bioepis Releases Q3 Biosimilar Market Trends Report21 July 2025 Samsung Bioepis released its Third Quarter 2025 United States Biosimilar Market Report today, providing an insight into industry…
MMedication Read More Sotagliflozin Shows Benefit When Added to Insulin for Type 1 Diabetes2 July 2025 Sotagliflozin added to insulin therapy reduced the risk of hypoglycemia, a potentially life-threatening low-blood-sugar condition, in patients with…